The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study

ABSTRACT Background Trimethylamine N-oxide (TMAO), a metabolite from red meat and fish consumption, plays a role in promoting cardiovascular events. However, data regarding TMAO and its impact on clinical outcomes are inconclusive, possibly due to its undetermined dietary source. Objectives We hypothesized that circulating TMAO derived from fish intake might cause less harm compared with red meat sources by examining the concomitant level of 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), a known biomarker of fish intake, and investigated the association between TMAO, CMPF, and outcomes. Methods Patients were recruited from the European QUALity (EQUAL) Study on treatment in advanced chronic kidney disease among individuals aged ≥65 y whose estimated glomerular filtration rate (eGFR) had dropped for the first time to ≤20 mL/min per 1.73 m2 during the last 6 mo. The association between TMAO, CMPF, and outcomes including all-cause mortality and kidney replacement therapy (KRT) was assessed among 737 patients. Patients were further stratified by median cutoffs of TMAO and CMPF, suggesting high/low red meat and fish intake. Results During a median of 39 mo of follow-up, 232 patients died. Higher TMAO was independently associated with an increased risk of all-cause mortality (multivariable HR: 1.46; 95% CI: 1.17, 1.83). Higher CMPF was associated with a reduced risk of both all-cause mortality (HR: 0.79; 95% CI: 0.71, 0.89) and KRT (HR: 0.80; 95% CI: 0.71, 0.90), independently of TMAO and other clinically relevant confounders. In comparison to patients with low TMAO and CMPF, patients with low TMAO and high CMPF had reduced risk of all-cause mortality (adjusted HR: 0.49; 95% CI: 0.31, 0.73), whereas those with high TMAO and high CMPF showed no association across adjusted models. Conclusions High CMPF conferred an independent role in health benefits and might even counteract the unfavorable association between TMAO and outcomes. Whether higher circulating CMPF concentrations are due to fish consumption, and/or if CMPF is a protective factor, remains to be verified.

[1]  S. Hazen,et al.  Circulating trimethylamine N-oxide levels following fish or seafood consumption , 2022, European Journal of Nutrition.

[2]  R. Giacco,et al.  Plasma TMAO increase after healthy diets: results from 2 randomized controlled trials with dietary fish, polyphenols, and whole-grain cereals. , 2021, The American journal of clinical nutrition.

[3]  V. Chitalia,et al.  Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease , 2021, Nature Reviews Nephrology.

[4]  Z. Massy,et al.  Translational Science Diet-Microbiota Interaction and Kidney Disease Progression. , 2020, Kidney international.

[5]  W. Garrett,et al.  Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function , 2020, Science.

[6]  Fabresse Nicolas,et al.  Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: comparison of rapid equilibrium dialysis and ultrafiltration. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[7]  S. Hazen,et al.  Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Oliver Fiehn,et al.  A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors , 2020, Cell.

[9]  M. Vaneechoutte,et al.  Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. , 2020, Kidney international.

[10]  L. Brennan,et al.  The Relationship between Fish Intake and Urinary Trimethylamine-N-Oxide. , 2019, Molecular nutrition & food research.

[11]  Peihong Chen,et al.  Serum 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid is associated with lipid profiles and might protect against non‐alcoholic fatty liver disease in Chinese individuals , 2018, Journal of diabetes investigation.

[12]  A. Sinclair,et al.  3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid (CMPF): A metabolite identified after consumption of fish oil and fish , 2018 .

[13]  M. Laville,et al.  Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients? , 2018, Toxins.

[14]  F. Dekker,et al.  Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study. , 2018, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[15]  P. Stenvinkel,et al.  Red meat intake in chronic kidney disease patients: Two sides of the coin. , 2018, Nutrition.

[16]  Y. Liu,et al.  CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis , 2017, EBioMedicine.

[17]  M. Connelly,et al.  TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function , 2017, Scientific Reports.

[18]  E. Tai,et al.  Meat and Seafood Consumption in Relation to Plasma Metabolic Profiles in a Chinese Population: A Combined Untargeted and Targeted Metabolomics Study , 2017, Nutrients.

[19]  J. Manson,et al.  Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies , 2017, Journal of the American Heart Association.

[20]  S. Mayne,et al.  Identifying biomarkers of dietary patterns by using metabolomics. , 2017, The American journal of clinical nutrition.

[21]  C. Cho,et al.  Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire? , 2017, Trends in Endocrinology & Metabolism.

[22]  N. Powe,et al.  Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. , 2017, Journal of the American Society of Nephrology : JASN.

[23]  Brian J. Bennett,et al.  Microbiota‐Dependent Metabolite Trimethylamine N‐Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA) , 2016, Journal of the American Heart Association.

[24]  R. Sinha,et al.  Comparing metabolite profiles of habitual diet in serum and urine. , 2016, The American journal of clinical nutrition.

[25]  D. Kuypers,et al.  Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. , 2016, Journal of the American Society of Nephrology : JASN.

[26]  O. Djurdjev,et al.  Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. , 2016, Kidney international.

[27]  Y. Liu,et al.  Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. , 2016, Cell reports.

[28]  S. Hazen,et al.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.

[29]  J. Spertus,et al.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. , 2016, Journal of the American Society of Nephrology : JASN.

[30]  A. von Eckardstein,et al.  Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. , 2015, Atherosclerosis.

[31]  Yan He,et al.  Dysbiosis of Gut Microbiota With Reduced Trimethylamine‐N‐Oxide Level in Patients With Large‐Artery Atherosclerotic Stroke or Transient Ischemic Attack , 2015, Journal of the American Heart Association.

[32]  Lorien S. Dalrymple,et al.  Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[33]  S. Hazen,et al.  Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease , 2015, Circulation research.

[34]  D. Fogarty,et al.  Do patients with chronic kidney disease get optimal cardiovascular risk reduction? , 2014, Current opinion in nephrology and hypertension.

[35]  I. G. Fantus,et al.  The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. , 2014, Cell metabolism.

[36]  M. Otagiri,et al.  A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. , 2012, Biochemical pharmacology.

[37]  F. Dekker,et al.  The EQUAL study: a European study in chronic kidney disease stage 4 patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  T. Niwa,et al.  Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production , 2012, Analytical and Bioanalytical Chemistry.

[39]  S. Mitchell,et al.  Dimethylamine and diet. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[41]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[42]  K. Kalantar-Zadeh,et al.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.

[43]  S. Mitchell,et al.  Dietary precursors of trimethylamine in man: a pilot study. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.